Induction of anti-tumor CTL immunity through in vivo triggering of 4-1BB and/ or CD40

Details for Australian Patent Application No. 2003225431 (hide)

Owner Leiden University Medical Center

Inventors Offringa, Rienk; Van Mierlo, Geertje; TOES, Rene; Diehl, Linda; Melief, Cornelis, J., M.

Agent Spruson & Ferguson

Pub. Number AU-B-2003225431

PCT Number PCT/NL03/00254

PCT Pub. Number WO2003/084999

Priority 10/115,620 04.04.02 US

Filing date 4 April 2003

Wipo publication date 20 October 2003

Acceptance publication date 27 July 2006

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 10/115,620 04.04.02 US

27 November 2003 Application Open to Public Inspection

  Published as AU-B-2003225431

18 November 2004 Amendment Made

  The nature of the amendment is: Delete inventor Mittler, Robert, S.

27 July 2006 Application Accepted

  Published as AU-B-2003225431

23 November 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003225432-DELIVERY OF A SUBSTANCE TO A PRE-DETERMINED SITE

2003225430-COMPOSITION AND METHOD FOR THE TREATMENT OR PREVENTION OF IL-1 MEDIATED DISORDERS